---
title: "__NewInstitue__ Quality Manual"
subtitle: "SOP-006: Outsourced Activities Procedure"
---

## 1.0 PURPOSE

This Standard Operating Procedure (SOP) establishes requirements for selecting,
qualifying, contracting, and overseeing external organizations that perform
*observational study* activities on behalf of __NewInstitute__.

This procedure ensures that:

- External organizations are qualified before performing study-related activities
- Written agreements define transferred duties and responsibilities
- Oversight is maintained throughout the engagement
- Quality standards are equivalent to internally conducted work

While __NewInstitute__ may transfer study-related duties and functions to an
external organization, ultimate responsibility for the quality and integrity of
study data remains with __NewInstitute__.

## 2.0 SCOPE

This procedure applies to the selection, qualification, contracting, and
oversight of external organizations that perform study-related activities on
behalf of __NewInstitute__ for *observational studies*.

For purposes of this procedure, "external organization" includes any person or
organization outside of __NewInstitute__ contracted to perform study-related
activities, such as clinical sites, investigators, laboratories, and service
providers.

External organizations are qualified on a study-by-study basis. The type and
extent of controls applied **SHALL** be proportionate to the potential impact
on subject safety, data integrity, and study validity, as determined through
risk assessment per
[SOP-003: Risk Management and Quality Risk Management Procedure](SOP-003--Risk_Management_and_Quality_Risk_Management_Procedure.md).

This procedure does not apply to sponsor-investigator scenarios where
__NewInstitute__ personnel serve as the investigator; qualification
requirements for these scenarios are addressed under
[SOP-001: Design Controls Procedure](SOP-001--Design_Controls_Procedure.md).

Operational monitoring of study conduct (including activities performed by
external organizations) is managed under
[SOP-009: Monitoring and Oversight Procedure](SOP-009--Monitoring_and_Oversight_Procedure.md).

Vendor computer systems are subject to assessment under
[SOP-004: Computer System Validation, Data Integrity and Data Management Procedure](SOP-004--Computer_System_Validation_Data_Integrity_and_Data_Management_Procedure.md).

Vendor-generated documents are controlled under
[SOP-002: Document and Records Controls Procedure](SOP-002--Document_and_Records_Controls_Procedure.md)
and maintained in the TMF.

Audits of external organizations are conducted according to
[SOP-012: Internal and External Audit Procedure](SOP-012--Internal_and_External_Audit_Procedure.md).

Vendor performance issues may trigger
[SOP-010: Control of Nonconforming Observational Study Activities Procedure](SOP-010--Control_of_Nonconforming_Observational_Study_Activities_Procedure.md)
or [SOP-011: Corrective and Preventive Action Procedure](SOP-011--Corrective_and_Preventive_Action_Procedure.md).

This procedure applies to all __NewInstitute__ employees and subcontractors
involved in:

- External organization selection and qualification
- Contract and agreement development
- External organization oversight
- Quality assurance

## 3.0 REFERENCES, TERMS AND ACRONYMS

### 3.1 Guidance and Regulatory References

- [ICH E6(R2)](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e6r2-good-clinical-practice-integrated-addendum-ich-e6r1):
  Good Clinical Practice: Integrated Addendum to ICH E6(R1)
  - Section 5.2 (Contract Research Organization)
  - Section 5.23 (Multicenter Trials)

- [ISO 9001:2015](https://www.iso.org/standard/62085.html):
  Quality management systems â€” Requirements
  - Section 8.4 (Control of externally provided processes, products and services)

### 3.2 __NewInstitute__ References

1. [QM-001: Quality Manual](QM-001--QualityManual.md)

2. [SOP-001: Design Controls Procedure](SOP-001--Design_Controls_Procedure.md)

3. [SOP-002: Document and Records Controls
   Procedure](SOP-002--Document_and_Records_Controls_Procedure.md)

4. [SOP-003: Risk Management and Quality Risk Management
   Procedure](SOP-003--Risk_Management_and_Quality_Risk_Management_Procedure.md)

5. [SOP-004: Computer System Validation, Data Integrity and Data Management
   Procedure](SOP-004--Computer_System_Validation_Data_Integrity_and_Data_Management_Procedure.md)

6. [SOP-009: Monitoring and Oversight
   Procedure](SOP-009--Monitoring_and_Oversight_Procedure.md)

7. [SOP-010: Control of Nonconforming Observational Study Activities
   Procedure](SOP-010--Control_of_Nonconforming_Observational_Study_Activities_Procedure.md)

8. [SOP-011: Corrective and Preventive Action
   Procedure](SOP-011--Corrective_and_Preventive_Action_Procedure.md)

9. [SOP-012: Internal and External Audit
   Procedure](SOP-012--Internal_and_External_Audit_Procedure.md)

### 3.3 Terms

- **Clinical Site**: A location where study-related activities are conducted,
  including subject recruitment, informed consent, study procedures, and data
  collection.

- **External Organization**: Any person or organization outside of
  __NewInstitute__ contracted to perform study-related activities. Includes
  clinical sites, investigators, laboratories, and service providers.

- **Investigator**: A person responsible for the conduct of the clinical trial
  at a trial site. If a trial is conducted by a team of individuals at a trial
  site, the investigator is the responsible leader of the team and may be called
  the principal investigator. [ICH E6(R2) Section 1.34]

- **Quality Agreement**: A written agreement between __NewInstitute__ and an
  external organization that defines quality expectations, responsibilities,
  and communication requirements.

- **Sub-contractor**: An organization engaged by an external organization to
  perform activities that have been transferred from __NewInstitute__ to the
  external organization.

### 3.4 Acronyms

- **CRO**: Contract Research Organization
- **CV**: Curriculum Vitae
- **GCP**: Good Clinical Practice
- **PI**: Principal Investigator
- **QA**: Quality Assurance
- **TMF**: Trial Master File

## 4.0 PROCEDURE

### 4.1 Overview

This procedure establishes requirements for:

- Identifying external organization needs
- Selecting and qualifying external organizations
- Establishing written agreements
- Maintaining oversight throughout the engagement
- Managing sub-contractors
- Addressing performance issues
- Requalifying or terminating external organizations

External organizations are qualified on a study-by-study basis. Qualification
documentation is maintained in the study TMF.

The type and extent of controls applied to external organizations **SHALL** be
proportionate to the potential impact on subject safety, data integrity, and
study validity.

### 4.2 Selection and Qualification

#### 4.2.1 Needs Identification

Before engaging an external organization, the need **SHALL** be documented,
including:

- Services required
- Scope of activities to be transferred
- Study-specific requirements
- Timeline and deliverables

#### 4.2.2 Selection Criteria

External organizations **SHALL** be evaluated against selection criteria
appropriate to the services required. Selection criteria **SHOULD** include:

- Relevant experience and expertise
- Capacity and availability
- Quality systems and processes
- Regulatory compliance history
- References from prior engagements
- Financial stability (for significant engagements)

For clinical sites and investigators, selection criteria **SHALL** also include:

- Investigator qualifications and training (per ICH E6(R2) Section 4.1)
- Access to the target subject population
- Adequate facilities and resources
- Regulatory standing (e.g., no debarment, no significant inspection findings)

#### 4.2.3 Qualification Assessment

Before an external organization performs study-related activities, a
qualification assessment **SHALL** be performed to verify capability and
suitability.

The qualification assessment **SHALL** be proportionate to risk and **MAY**
include:

- Review of standard operating procedures and quality documentation
- Review of regulatory inspection history
- Review of certifications, accreditations, or licenses
- Reference checks
- Capability questionnaire
- Qualification visit or call
- Review of investigator CV, medical license, and GCP training

For clinical sites, qualification **MAY** be performed through a site
feasibility assessment and pre-study visit.

#### 4.2.4 Qualification Decision and Documentation

The qualification decision **SHALL** be documented, including:

- External organization name and contact information
- Services to be provided
- Qualification assessment performed
- Qualification decision (approved, approved with conditions, not approved)
- Any conditions or limitations
- Approver and date

Qualification documentation **SHALL** be maintained in the study TMF.

### 4.3 Contracting

#### 4.3.1 Agreement Types

Written agreements **SHALL** be established with external organizations before
they perform study-related activities.

Agreement types include:

- **Contract or Service Agreement**: Defines the scope of work, deliverables,
  timeline, compensation, and legal terms
- **Quality Agreement**: Defines quality expectations, responsibilities, and
  communication requirements
- **Investigator Agreement**: For clinical sites, defines investigator
  responsibilities and commitments (e.g., Form FDA 1572 equivalent if applicable)
- **Confidentiality Agreement**: Protects confidential information and subject
  data

A single agreement may combine multiple agreement types.

#### 4.3.2 Required Agreement Content

Agreements with external organizations **SHALL** address, as applicable:

- Scope of transferred duties and functions
- Deliverables and acceptance criteria
- Timeline and milestones
- Responsibilities of each party
- Quality requirements and standards
- Regulatory compliance requirements
- Training requirements
- Communication and reporting requirements
- Access for monitoring and auditing
- Sub-contracting provisions (see Section 4.5)
- Confidentiality and data protection
- Record retention and access
- Issue escalation procedures
- Termination provisions
- Liability and indemnification

Any duties and functions not specifically transferred to and assumed by an
external organization are retained by __NewInstitute__.

#### 4.3.3 Agreement Review and Approval

Agreements **SHALL** be reviewed and approved before execution.

Review **SHALL** verify that:

- Scope of work aligns with study requirements
- Quality requirements are adequately defined
- Regulatory compliance requirements are addressed
- __NewInstitute__ oversight rights are preserved

Approved agreements **SHALL** be maintained in the study TMF.

### 4.4 Oversight and Performance Management

#### 4.4.1 Governance

Governance activities **SHALL** be established to maintain oversight of
external organizations, including:

- **Kick-off Meeting**: Conducted before activities begin to review study
  requirements, expectations, communication pathways, and escalation procedures
- **Regular Communication**: Ongoing communication appropriate to the scope and
  complexity of the engagement
- **Governance Meetings**: Periodic meetings to review progress, issues, and
  performance (frequency proportionate to risk and activity level)

#### 4.4.2 Performance Monitoring

External organization performance **SHALL** be monitored throughout the
engagement.

Performance monitoring **MAY** include:

- Review of deliverables against acceptance criteria
- Tracking of timelines and milestones
- Review of quality metrics
- Monitoring of issue resolution
- Review of reports and documentation

Performance concerns **SHALL** be documented and addressed per Section 4.6.

#### 4.4.3 Deliverable Review

Deliverables from external organizations **SHALL** be reviewed for:

- Completeness
- Accuracy
- Compliance with specifications and quality requirements
- Timeliness

Deliverable acceptance or rejection **SHALL** be documented.

#### 4.4.4 Audits

Audits of external organizations **MAY** be conducted to verify compliance with
agreements and quality requirements.

Audits **MAY** be triggered by:

- Risk assessment (high-risk services or activities)
- Performance concerns or quality issues
- Significant findings from monitoring activities
- Periodic reassessment
- For-cause investigation

Audit planning, conduct, and reporting **SHALL** follow
[SOP-012: Internal and External Audit Procedure](SOP-012--Internal_and_External_Audit_Procedure.md).

Audit findings **SHALL** be addressed per Section 4.6.

### 4.5 Sub-Contractor Management

#### 4.5.1 Sub-Contractor Approval

External organizations **SHALL NOT** sub-contract transferred activities
without prior written approval from __NewInstitute__, unless the agreement
explicitly permits specific sub-contracting arrangements.

Requests to sub-contract **SHALL** include:

- Proposed sub-contractor identification
- Scope of sub-contracted activities
- Sub-contractor qualifications
- Rationale for sub-contracting

__NewInstitute__ **SHALL** evaluate the proposed sub-contractor and approve or
reject the request.

#### 4.5.2 Flow-Down of Quality Requirements

External organizations **SHALL** ensure that applicable quality requirements
flow down to sub-contractors.

Sub-contractor agreements **SHALL** include:

- Quality requirements equivalent to the primary agreement
- __NewInstitute__ right to audit the sub-contractor
- Record retention and access requirements

The external organization remains responsible for sub-contractor performance.

### 4.6 Issue Management

#### 4.6.1 Issue Identification

Issues related to external organization performance **SHALL** be documented
when identified, including:

- Description of the issue
- Impact on study activities, data integrity, or subject safety
- Severity assessment

#### 4.6.2 Issue Resolution

Issues **SHALL** be communicated to the external organization and resolution
**SHALL** be tracked.

Resolution activities **MAY** include:

- Corrective action by the external organization
- Additional training or clarification
- Enhanced oversight or monitoring
- Modification of agreements or scope

#### 4.6.3 Escalation

Issues **SHALL** be escalated as appropriate:

- Protocol deviations **SHALL** be managed per
  [SOP-010: Control of Nonconforming Observational Study Activities Procedure](SOP-010--Control_of_Nonconforming_Observational_Study_Activities_Procedure.md)
- Systemic or recurring issues **SHALL** be evaluated for CAPA per
  [SOP-011: Corrective and Preventive Action Procedure](SOP-011--Corrective_and_Preventive_Action_Procedure.md)
- Significant quality failures **MAY** trigger requalification or termination
  per Section 4.7

### 4.7 Requalification and Termination

#### 4.7.1 Requalification

Requalification of an external organization **MAY** be required when:

- Significant changes occur to the external organization (ownership, key
  personnel, facilities, quality systems)
- Significant performance issues are identified
- Audit findings indicate systemic problems
- The external organization is engaged for a new study

Requalification **SHALL** follow the qualification process in Section 4.2.

#### 4.7.2 Termination

Termination of an external organization **MAY** be initiated when:

- Services are no longer required
- Performance issues cannot be adequately resolved
- Regulatory or compliance concerns arise
- Contractual obligations are not met

Termination **SHALL** be managed to ensure:

- Subject safety is protected
- Data integrity is maintained
- Records and deliverables are transferred or secured
- Transition of activities is orderly
- Termination is documented

Termination provisions in the agreement **SHALL** be followed.

## 5.0 TRAINING

All personnel involved in external organization management **SHALL** be trained
on this procedure and maintain documented evidence of training according to
[QM-001 Section 6.1.1](QM-001--QualityManual.md#611-people).

Training **SHALL** include:

- Selection and qualification requirements
- Contracting and agreement requirements
- Oversight and performance monitoring
- Sub-contractor management
- Issue identification and escalation

Training records **SHALL** be maintained per SOP-002.

## 6.0 RECORDS

The following records **SHALL** be maintained in the TMF:

| Record | Retention |
|--------|-----------|
| Needs identification documentation | Per SOP-002 |
| Selection evaluation documentation | Per SOP-002 |
| Qualification assessment documentation | Per SOP-002 |
| Qualification decision documentation | Per SOP-002 |
| Contracts and service agreements | Per SOP-002 |
| Quality agreements | Per SOP-002 |
| Investigator agreements | Per SOP-002 |
| Confidentiality agreements | Per SOP-002 |
| Investigator CVs and licenses | Per SOP-002 |
| GCP training documentation | Per SOP-002 |
| Kick-off meeting documentation | Per SOP-002 |
| Governance meeting records | Per SOP-002 |
| Performance monitoring records | Per SOP-002 |
| Deliverable acceptance records | Per SOP-002 |
| Sub-contractor approval documentation | Per SOP-002 |
| Issue documentation and resolution records | Per SOP-002 |
| Audit reports (per SOP-012) | Per SOP-002 |
| Requalification documentation | Per SOP-002 |
| Termination documentation | Per SOP-002 |
| Training records | Per SOP-002 |

External organizations are qualified on a study-by-study basis. All
qualification and oversight documentation is maintained in that study's TMF.
